Union Korea Pharm Co., Ltd. (KOSDAQ:A080720) announces a share repurchase program. Under the program, the company will repurchase up to 283,333 shares. The program is aimed at stock price stability and shareholder value enhancement.

The program will expire on September 21, 2022. As of June 21, 2022, the company had 400,000 shares in treasury within scope available for dividend and had no shares in treasury through other repurchases.